Company news

Prenetics Global Limited news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Prenetics Announces Participation in the Sidoti Virtual Micro Cap Investor Conference

October 29, 2024

Prenetics Announces Tencent’s US$30 Million Investment in Insighta, Strengthening Strategic Partnership for AI-Driven Early Cancer Detection

October 14, 2024

Prenetics Announces Second Quarter 2024 Financial Results

October 6, 2024

Prenetics Announces Acquisition of Europa Sports Partners in Strategic Expansion to Consumer Health and Wellness Industry

August 18, 2024

Prenetics Welcomes Kathyrn M. Henry and David Vanderveen to Board of Directors

June 30, 2024

Prenetics Announces First Quarter 2024 Financial Results

June 17, 2024

Prenetics Announces Fourth Quarter and Full Year 2023 Financial Results

March 31, 2024

Prenetics Announces MOU for a Strategic Investment and 5-Year Research Collaboration with Metavisionaries to Pioneer R&D on the International Space Station

February 8, 2024

Prenetics Announces Third Quarter 2023 Financial Results

November 19, 2023

Prenetics Global Limited Announces Reverse Stock Split

October 31, 2023

Prenetics Announces Second Quarter 2023 Financial Results

September 14, 2023

Prenetics Global signs "transformational" $200mln deal to create cancer screening JV

June 29, 2023

Prenetics and Globally Renowned Scientist Prof. Dennis Lo Establish US$200m Joint Venture "Insighta" for Breakthrough Multi-Cancer Early Detection Screening

June 24, 2023

Prenetics Announces First Quarter 2023 Financial Results

June 4, 2023

Prenetics Announces Fourth Quarter and Full Year 2022 Financial Results, New Business Strategy Focused on Precision Oncology

March 13, 2023

Prenetics Announces Fourth Quarter and Full Year 2022 Financial Results

March 13, 2023

Prenetics Announces Formation of Scientific Advisory Board to Support New Business Strategy in Precision Oncology

March 3, 2023

Prenetics Announces Dr. Bayju Thakar as Chief Executive Officer of Prenetics EMEA

January 18, 2023

Prenetics Owned ACT Genomics Receives FDA Clearance for ACTOnco, the First Asia-Based Company to Receive Clearance for a Comprehensive Genomic Profiling Test for All Solid Tumors

January 9, 2023

Prenetics Acquires ACT Genomics; First M&A Deal since IPO, Set to Expand Footprint in Cancer Genomics

December 15, 2022

Prenetics Acquires ACT Genomics, Creating a Leader in Comprehensive Cancer Genetics and Precision Oncology

December 15, 2022

Prenetics Announces US$20 Million Stock Repurchase Program and Inclusion into the MSCI Global Micro Cap Index

November 29, 2022

Prenetics Announces Record Third Quarter 2022 Financial Results and Raises Full Year 2022 Revenue and EBITDA Guidance

November 9, 2022

Prenetics Announces Second Quarter 2022 Financial Results and Raises Full Year Adjusted EBITDA Outlook

September 8, 2022

Prenetics Announces Second Quarter 2022 Financial Results and Raises Full Year Adjusted EBITDA Outlook

September 8, 2022

Prenetics Announces First Quarter 2022 Financial Results After a Successful Listing on the Nasdaq under the Ticker “PRE.”

June 5, 2022

← Newer news releases

Calls

Decks